Inventor · disambiguated record
Aranapakam Venkatesan
Also filed as: VENKATESAN ARANAPAKAM · VENKATESAN ARANAPAKAM M · VENKATESAN ARANAPAKAM MADUMBAI
21 granted patents·6 pending applications·48 citations·filing 2003–2021
94Inventor score
Top patents by PatentIndex Score
27 records- 0190US11103491B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2020·Granted Aug 31, 2021·2 cites·12 claims
- 0289US9908879B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2016·Granted Mar 6, 2018·5 cites·43 claims
- 0386US9944637B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2014·Granted Apr 17, 2018·5 cites·30 claims
- 0486US9382277B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·8 cites·28 claims
- 0585US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 0684US10751332B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Aug 25, 2020·2 cites·7 claims
- 0783US10316039B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2018·Granted Jun 11, 2019·2 cites·3 claims
- 0882US10471051B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2017·Granted Nov 12, 2019·3 cites·38 claims
- 0982US9896445B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Feb 20, 2018·3 cites·27 claims
- 1082US8729079B2Pyrimido-pyridazinone compounds and methods of use thereofVENKATESAN ARANAPAKAM·Filed 2012·Granted May 20, 2014·8 cites·25 claims
- 1180US10647720B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2018·Granted May 12, 2020·1 cites·33 claims
- 1279US10544145B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2019·Granted Jan 28, 2020·1 cites·17 claims
- 1378US10590127B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2018·Granted Mar 17, 2020·1 cites·32 claims
- 1476US11925629B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2021·Granted Mar 12, 2024·0 cites·14 claims
- 1575US11685736B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2019·Granted Jun 27, 2023·0 cites·44 claims
- 1672US10183944B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2016·Granted Jan 22, 2019·1 cites·26 claims
- 1769US9371316B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 21, 2016·0 cites·18 claims
- 1869US9266873B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Feb 23, 2016·0 cites·10 claims
- 1967US7153849B2Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxansWYETH CORP·Filed 2003·Granted Dec 26, 2006·3 cites·52 claims
- 2066US2020190095A1Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 2165US9533981B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2013·Granted Jan 3, 2017·0 cites·21 claims
- 2260US2017073339A1Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2016·Application pending·0 cites
- 2352US2006276481A1Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxansWYETH CORP·Filed 2006·Application pending·0 cites
- 2452US2016222014A1Compounds for regulating fak and/or src pathwaysASANA BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
- 2549US9145411B2Substituted amino-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2013·Granted Sep 29, 2015·0 cites·21 claims
- 2642US2016304617A15t4-targeted immunofusion molecule and methodsASANA BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
- 2741US2016016952A1Substituted amino-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aranapakam Venkatesan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →